Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke

Neuroscience Letters

Volumn 398, Issue 3, 2006, Pages 172-177

  Gao, XuGuang ^a   Yang, Huo ^a   ZhiPing, Teng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

ACE; APOE; Fg ; Ischemic stroke; MTHFR; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); APOLIPOPROTEIN E; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN; THREONINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANALYTIC METHOD; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; RISK; RISK FACTOR; SMOKING; STROKE;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; DISEASE SUSCEPTIBILITY; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; HYPERTENSION; INCIDENCE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN; RISK FACTORS; SMOKING;

EID: 33646339153     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.12.078     Document Type: Article

References (30)

1. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., and Marsh E.E.I. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
2. Bak S., Gaist D., Sindrup S.H., Skytthe A., and Christensen K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 33 (2002) 769-774
3. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nat. Rev. Genet. 2 (2001) 91-99
4. Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 (1988) 1-21
5. Fang X.H., Kronmal R.A., Li S.C., Longstreth Jr. W.T., Cheng X.M., Wang W.Z., Wu S., Du X.L., and Siscovick D. Prevention of stroke in urban China: a community-based intervention trial. Stroke 30 (1999) 495-501
6. van Goor M.P., Gomez-Garcia E.B., Leebeek F.W., Brouwers G.J., Koudstaal P.J., and Dippel D.W. The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. J. Neurol. Neurosurg. Psychiatry 76 (2005) 121-123
7. Harrap S.B., Tzourio C., Cambien F., Poirier O., Raoux S., Chalmers J., Chapman N., Colman S., Leguennec S., MacMahon S., Neal B., Ohkubo T., and Woodward M. PROGRESS Collaborative Group, The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 42 (2003) 297-303
8. van't Hooft F.M., von Bahr S.J., Silveira A., Iliadou A., Eriksson P., and Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 3063-3070
9. Humphries S.E., Luong L.A., Montgomery H.E., Day I.N., Mohamed-Ali V., and Yudkin J.S. Gene-environment interaction in the determination of levels of plasma fibrinogen. Thromb. Haemost. 82 (1999) 818-825
10. Humphries S.E., Talmud P.J., Hawe E., Bolla M., Day I.N., and Miller G.J. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358 (2001) 115-119
11. Jeffs B., Clark J.S., Anderson N.H., Gratton J., Brosnan M.J., Gauguier D., Reid J.L., Macrae I.M., and Dominiczak A.F. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat. Genet. 16 (1997) 364-367
12. Jerrard-Dunne P., Cloud G., Hassan A., and Markus H.S. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 34 (2003) 1364-1369
13. Kelly P.J., Rosand J., Kistler J.P., Shih V.E., Silveira S., Plomaritoglou A., and Furie K.L. Homocysteine, MTHFR 677C → T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59 (2002) 529-536
14. Lavenson Jr. G.S., Pantera R.L., Garza R.M., Neff T., Rothwell S.D., and Cisneros J. Development and implementation of a rapid, accurate, and cost-effective protocol for national stroke prevention screening. Am. J. Surg. 188 (2004) 638-643
15. Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B., Zhu Z., Zhao J., Ma A., Han Y., Wang Y., Shi Y., Ye J., and Hui R. Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34 (2003) 2085-2090
16. Liao D., Myers R., Hunt S., Shahar E., Paton C., Burke G., Province M., and Heiss G. Familial history of stroke and stroke risk. The Family Heart Study. Stroke 28 (1997) 1908-1912
17. Lin H.F., Lai C.L., Tai C.T., Lin R.T., and Liu C.K. Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia patients in Taiwan. Neuroepidemiology 23 (2004) 129-134
18. Lin J.J., Yueh K.C., Lin G.Y., Chang D.C., Chang C.Y., Shieh H.L., and Harn H.J. Lack of association between angiotensin I-converting enzyme gene deletion polymorphism and cerebrovascular disease in Taiwanese. J. Formos. Med. Assoc. 99 (2000) 895-901
19. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
20. Pezzini A., Grassi M., Del Zotto E., Archetti S., Spezi R., Vergani V., Assanelli D., Caimi L., and Padovani A. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 36 (2005) 533-539
21. Pezzini A., Grassi M., Del Zotto E., Bazzoli E., Archetti S., Assanelli D., Akkawi N.M., Albertini A., and Padovani A. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke 35 (2004) 438-442
22. Pfohl M., Fetter M., Koch M., Barth C.M., Rudiger W., and Haring H.U. Association between angiotensin I-converting enzyme genotypes, extracranial artery stenosis, and stroke. Atherosclerosis 140 (1998) 161-166
23. Richard P., Thomas G., de Zulueta M.P., De Gennes J.L., Thomas M., Cassaigne A., Bereziat G., and Iron A. Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin. Chem. 40 (1994) 24-29
24. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
25. Schmidt H., Schmidt R., Niederkorn K., Horner S., Becsagh P., Reinhart B., Schumacher M., Weinrauch V., and Kostner G.M. Beta-fibrinogen gene polymorphism (C148 → T) is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 487-492
26. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., Fodor L., Bene J., and Melegh B. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1615-1620
27. Talmud P.J., Stephens J.W., Hawe E., Demissie S., Cupples L.A., Hurel S.J., Humphries S.E., and Ordovas J.M. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann. Hum. Genet. 69 (2005) 613-622
28. Thomas A., Lamlum H., Humphries S., and Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A -455 (HaeIII), C/T -148 (HindIII/AluI), T/G + 1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR. Hum. Mutat. 3 (1994) 79-81
29. Warlow C., Sudlow C., Dennis M., Wardlaw J., and Sandercock P. Stroke. Lancet 362 (2003) 1211-1224
30. Zhang G., and Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb. Res. 104 (2001) 187-195